Back to Search
FRANK HALUSKA, M.D.
M.D.
Medical Oncology Physician
NPI: 1942302559Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
73833(MA)
Research & Publications (20)
The RTK/RAS/BRAF/PI3K pathways in melanoma: biology, small molecule inhibitors, and potential applications.
PMID 18083378·Semin Oncol·2007
6-review
Molecular pathogenesis of cutaneous melanocytic neoplasms.
PMID 19400696·Annu Rev Pathol·2009
6-review
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice.
PMID 19398955·Oncogene·2009
7-preclinical
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.
PMID 18287062·Proc Natl Acad Sci U S A·2008
3-trial
Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
PMID 17577228·Cancer·2007
4-observational
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
PMID 17513813·J Clin Oncol·2007
4-observational
Novel inhibitors in the treatment of metastatic melanoma.
PMID 17492934·Expert Rev Anticancer Ther·2007
6-review
Phase II study of temozolomide and thalidomide in patients with metastatic melanoma in the brain: high rate of thromboembolic events (CALGB 500102).
PMID 16986123·Cancer·2006
3-trial
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
PMID 16966688·J Clin Oncol·2006
2-rct
Innovations and challenges in melanoma: summary statement from the first Cambridge conference.
PMID 16609047·Clin Cancer Res·2006
8-other
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.
PMID 16417231·J Invest Dermatol·2006
8-other
Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity.
PMID 16278389·Clin Cancer Res·2005
3-trial
Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute.
PMID 15714125·Melanoma Res·2005
4-observational
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
PMID 15118073·N Engl J Med·2004
8-other
Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
PMID 15034078·J Immunol·2004
8-other
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
PMID 15009714·J Invest Dermatol·2004
8-other
Skin cancer prevention and detection practices among siblings of patients with melanoma.
PMID 14512908·J Am Acad Dermatol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 750 WASHINGTON ST, NEMC BOX #7105
BOSTON, MA 02111 - Phone
- (617) 636-5000
Quick Facts
- NPI
- 1942302559
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile